ライフサイエンスコーパス: electrical cardioversion

1 12, 95% confidence interval 0.01 to 1.0, for electrical cardioversion).

2 sode of atrial flutter that was treated with electrical cardioversion.

3 toration of sinus rhythm by pharmacologic or electrical cardioversion.

4 to be resistant to most chemical methods and electrical cardioversion.

5 able in selected ICD patients presenting for electrical cardioversion.

6 e converted to sinus rhythm by transthoracic electrical cardioversion.

7 chocardiography immediately before and after electrical cardioversion.

8 n lasting longer than 2 days and were having electrical cardioversion.

9 During 144 electrical cardioversions, 209 shocks were delivered to

10 Recommendations are made for defibrillation, electrical cardioversion, advanced airway management, dr

11 n to anticoagulation, rhythm management with electrical cardioversion, amiodarone, or both is preferr

12 of sinus rhythm, as well as the efficacy of electrical cardioversion and the use of echocardiography

13 ot convert after ibutilide were treated with electrical cardioversion, and 35 (90%) of 39 patients we

14 y data about edoxaban in patients undergoing electrical cardioversion are available.

15 ardioversion through commanded ICD shock for electrical cardioversion are used for rhythm-control.

16 of atrial fibrillation (AF) after successful electrical cardioversion (CV).

17 Patients who undergo electrical cardioversion display a greater degree and a

18 We compared the incidence of electrical cardioversion (ECV), pharmacologic cardiovers

19 Standard external electrical cardioversion fails to restore sinus rhythm i

20 patients with obesity (BMI >=35) undergoing electrical cardioversion for atrial fibrillation, dual D

21 e 18 years or older, and planned nonemergent electrical cardioversion for atrial fibrillation.

22 hm Management trial, the Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillat

23 al flutter with a history of AF, planned for electrical cardioversion from 5 hospitals in the US, Can

24 Electrical cardioversion immediately restored sinus rhyt

25 Biphasic electrical cardioversion in cardiosurgical ICU patients

26 Electrical cardioversion in patients with atrial fibrill

27 sinus rhythm, but the efficacy of repetitive electrical cardioversion in restoring sinus rhythm was d

28 Immediate electrical cardioversion is indicated when the arrhythmi

29 Early access to electrical cardioversion is the key to survival.

30 le patients with new onset AF, conversion by electrical cardioversion is the preferred approach; howe

31 with atrial fibrillation who are to undergo electrical cardioversion is to prescribe warfarin for an

32 o patients underwent cardioversion (group I, electrical cardioversion, n = 40; group II, pharmacologi

33 h enoxaparin-warfarin in patients undergoing electrical cardioversion of non-valvular atrial fibrilla

34 Electrical cardioversion of patients with atrial fibrill

35 ibrillation (AF) >2 days duration undergoing electrical cardioversion over an eight-week period.

36 Management (AFFIRM) and Rate Control Versus Electrical Cardioversion (RACE) trials that anticoagulat

37 patients with AF >2 days duration undergoing electrical cardioversion, the TEE-guided group showed li

38 Electrical cardioversion using synchronized biphasic sho

39 Electrical cardioversion was attempted in 4 patients wit

40 ours, arrhythmia-related hospitalization, or electrical cardioversion were compared.

41 alike since the former proscribe the use of electrical cardioversion while the latter provide this p